Skip to content

Research on a Microneedle-Integrated System for Smart Diabetes Management via Glucose Fluorescent Sensing and Infrared-Responsive Drug Delivery

Research on a Microneedle-Integrated System for Smart Diabetes Management via Glucose Fluorescent Sensing and Infrared-Responsive Drug Delivery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110399
Enrollment
Unknown
Registered
2025-10-13
Start date
2025-10-13
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes.

Interventions

Diabetic patient:None
Nursing staff :None

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Diabetic patient 1.Age >= 18 years, all genders. 2.Meet the diagnostic criteria for Type 1 Diabetes Mellitus (T1DM) or Type 2 Diabetes Mellitus (T2DM) as per the China Guidelines for the Prevention and Treatment of Diabetes (2024 Edition). 3.Disease duration >= 3 years, with a treatment regimen of insulin >= 2 times/day or oral hypoglycemic agents >= 1 time/day. 4.Normal cognitive function (Mini-Mental State Examination (MMSE) score >= 27), fluent verbal expression, and no reading impairment. 5.Willing to participate and provide written informed consent. Nursing staff 1. Age >= 18 years; 2. Level N2-N4 in the Endocrinology Department (N2 = Nurse, N3 = Charge Nurse, N4 = Senior Nurse), with at least 1 year of experience in diabetes care; 3. Responsible for blood glucose monitoring, insulin injection guidance, or nursing management for diabetes patients, and have participated in at least one blood glucose management quality improvement project; 4. Normal cognitive function, good communication skills, and voluntary participation.

Exclusion criteria

Exclusion criteria: Exclusion criteria for nursing staff 1. Advanced practice nurses and rotating nurses (insufficient job stability); 2. Those with severe physical or mental illnesses who cannot complete the interview; 3. Those who have not directly participated in blood glucose management for diabetes patients in the past 3 months.

Design outcomes

Primary

MeasureTime frame
Adherence (MMAS-8);

Secondary

MeasureTime frame
Comfort (0-10 NRS);Pain intensity on the Numeric Rating Scale (NRS, 0–10);

Countries

China

Contacts

Public ContactJia Zhang

The Affiliated Hospital of Southwest Medical University

1852444039@qq.com+86 830 316 5273

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026